Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Phoenix: a global destination for bioscience and healthcare innovators
- Phoenix named top 10 city for great downtown living experience.
- Wexford Science & Technology launches Connect Labs, a new life science coworking space on the Phoenix Bioscience Core
- TGen, University of Wisconsin researchers use machine learning to make early detection of cancer more accessible
- NAU’s Occupational Therapy Program receives 10-year reaccreditation
- Northern Arizona University PA student goes to Washington to advocate for Dreamers like herself
- Meet Exact Sciences: The PBC company behind Cologuard